A large real-world study found no significant increase in short-term heart attack or stroke risk among migraine patients using triptans, including those with cardiovascular risk factors.
Large language models used in clinical decision-making may offer different treatment recommendations depending on how a patient writes their message—even when the medical facts remain unchanged.
A small observational study found that liraglutide, a GLP-1 receptor agonist typically used to treat diabetes and support weight loss, significantly reduced migraine frequency in adults with a BMI of 30 or higher—independent of weight change.
A large study has found that frequent nightmares in adults are linked to faster biological aging and a significantly higher risk of dying before age 75, highlighting a potential warning sign for long-term health risks.